- Home
- AXSM vs CPRI Comparison
AXSM vs CPRI Comparison
Compare AXSM & CPRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- CPRI
- Stock Information
- Founded
- AXSM 2012
- CPRI 1981
- Country
- AXSM United States
- CPRI United Kingdom
- Employees
- AXSM N/A
- CPRI N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- CPRI Apparel
- Sector
- AXSM Health Care
- CPRI Consumer Discretionary
- Exchange
- AXSM Nasdaq
- CPRI Nasdaq
- Market Cap
- AXSM 5.1B
- CPRI 2.2B
- IPO Year
- AXSM 2015
- CPRI 2011
- Fundamental
- Price
- AXSM $116.62
- CPRI $21.83
- Analyst Decision
- AXSM Strong Buy
- CPRI Buy
- Analyst Count
- AXSM 17
- CPRI 11
- Target Price
- AXSM $175.76
- CPRI $23.64
- AVG Volume (30 Days)
- AXSM 576.1K
- CPRI 2.6M
- Earning Date
- AXSM 11-11-2025
- CPRI 11-06-2025
- Dividend Yield
- AXSM N/A
- CPRI N/A
- EPS Growth
- AXSM N/A
- CPRI N/A
- EPS
- AXSM N/A
- CPRI N/A
- Revenue
- AXSM $495,033,000.00
- CPRI $4,391,000,000.00
- Revenue This Year
- AXSM $63.78
- CPRI N/A
- Revenue Next Year
- AXSM $55.74
- CPRI $3.87
- P/E Ratio
- AXSM N/A
- CPRI N/A
- Revenue Growth
- AXSM 69.83
- CPRI N/A
- 52 Week Low
- AXSM $75.56
- CPRI $11.86
- 52 Week High
- AXSM $139.13
- CPRI $43.34
- Technical
- Relative Strength Index (RSI)
- AXSM 48.36
- CPRI 56.30
- Support Level
- AXSM $112.90
- CPRI $20.42
- Resistance Level
- AXSM $130.00
- CPRI $21.96
- Average True Range (ATR)
- AXSM 3.70
- CPRI 0.96
- MACD
- AXSM -1.47
- CPRI -0.03
- Stochastic Oscillator
- AXSM 21.75
- CPRI 82.30
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About CPRI Capri Holdings Limited
Capri Holdings is a marketer, distributor, and retailer of upscale accessories and apparel in the Americas, Europe, and Asia. Michael Kors, Capri's original and largest brand by sales, offers handbags, footwear, and apparel through more than 700 company-owned stores, wholesale, and e-commerce. Jimmy Choo (acquired in 2017) is best known for women's luxury footwear. Its products are sold in more than 200 company-operated stores. Capri also owns a third brand, Versace, but has agreed to sell it to Prada. John Idol has served as Capri's CEO since 2003.